Search research articles
Contact Us
Filters
Showing results (361-370 of 393) with videos related to
Page
of 40
Sort By:
American Journal of Human Genetics
|
December 9, 2022
An intronic GAA repeat expansion in FGF14 causes the autosomal-dominant adult-onset ataxia SCA50/ATX-FGF14
Haloom Rafehi, Justin Read, David J Szmulewicz, et al.
Annals of Neurology
|
April 12, 2022
Heterozygous PNPT1 Variants Cause Spinocerebellar Ataxia Type 25
Mathieu Barbier, Melanie Bahlo, Alessandra Pennisi, et al.
Annals of Neurology
|
September 12, 2024
Clinical, Radiological and Pathological Features of a Large American Cohort of Spinocerebellar Ataxia (SCA27B)
Widad Abou Chaar, Anirudh N Eranki, Hannah A Stevens, et al.
Nature Genetics
|
September 29, 2014
Mutations in SPRTN cause early onset hepatocellular carcinoma, genomic instability and progeroid features
Davor Lessel, Bruno Vaz, Swagata Halder, et al.
American Journal of Human Genetics
|
June 25, 2019
Bioinformatics-Based Identification of Expanded Repeats: A Non-reference Intronic Pentamer Expansion in RFC1 Causes CANVAS
Haloom Rafehi, David J Szmulewicz, Mark F Bennett, et al.
Acta Neuropathologica
|
February 28, 2016
Germline and somatic FGFR1 abnormalities in dysembryoplastic neuroepithelial tumors
Barbara Rivera, Tenzin Gayden, Jian Carrot-Zhang, et al.
Neuron
|
February 26, 2020
Pathogenic Variants in CEP85L Cause Sporadic and Familial Posterior Predominant Lissencephaly
Meng-Han Tsai, Alison M Muir, Won-Jing Wang, et al.
American Journal of Human Genetics
|
December 1, 2014
Mutations in RAB39B cause X-linked intellectual disability and early-onset Parkinson disease with α-synuclein pathology
Gabrielle R Wilson, Joe C H Sim, Catriona McLean, et al.
The New England Journal of Medicine
|
August 11, 2016
Treatment of Fabry's Disease with the Pharmacologic Chaperone Migalastat
Dominique P Germain, Derralynn A Hughes, Kathleen Nicholls, et al.
Journal of Medical Genetics
|
November 12, 2016
Oral pharmacological chaperone migalastat compared with enzyme replacement therapy in Fabry disease: 18-month results from the randomised phase III ATTRACT study
Derralynn A Hughes, Kathleen Nicholls, Suma P Shankar, et al.
Page
of 40
Search research articles
Search
Showing results (361-370 of 393) with videos related to
Sort By:
Page
of 40
American Journal of Human Genetics
|
December 9, 2022
An intronic GAA repeat expansion in FGF14 causes the autosomal-dominant adult-onset ataxia SCA50/ATX-FGF14
Haloom Rafehi, Justin Read, David J Szmulewicz, et al.
Annals of Neurology
|
April 12, 2022
Heterozygous PNPT1 Variants Cause Spinocerebellar Ataxia Type 25
Mathieu Barbier, Melanie Bahlo, Alessandra Pennisi, et al.
Annals of Neurology
|
September 12, 2024
Clinical, Radiological and Pathological Features of a Large American Cohort of Spinocerebellar Ataxia (SCA27B)
Widad Abou Chaar, Anirudh N Eranki, Hannah A Stevens, et al.
Nature Genetics
|
September 29, 2014
Mutations in SPRTN cause early onset hepatocellular carcinoma, genomic instability and progeroid features
Davor Lessel, Bruno Vaz, Swagata Halder, et al.
American Journal of Human Genetics
|
June 25, 2019
Bioinformatics-Based Identification of Expanded Repeats: A Non-reference Intronic Pentamer Expansion in RFC1 Causes CANVAS
Haloom Rafehi, David J Szmulewicz, Mark F Bennett, et al.
Acta Neuropathologica
|
February 28, 2016
Germline and somatic FGFR1 abnormalities in dysembryoplastic neuroepithelial tumors
Barbara Rivera, Tenzin Gayden, Jian Carrot-Zhang, et al.
Neuron
|
February 26, 2020
Pathogenic Variants in CEP85L Cause Sporadic and Familial Posterior Predominant Lissencephaly
Meng-Han Tsai, Alison M Muir, Won-Jing Wang, et al.
American Journal of Human Genetics
|
December 1, 2014
Mutations in RAB39B cause X-linked intellectual disability and early-onset Parkinson disease with α-synuclein pathology
Gabrielle R Wilson, Joe C H Sim, Catriona McLean, et al.
The New England Journal of Medicine
|
August 11, 2016
Treatment of Fabry's Disease with the Pharmacologic Chaperone Migalastat
Dominique P Germain, Derralynn A Hughes, Kathleen Nicholls, et al.
Journal of Medical Genetics
|
November 12, 2016
Oral pharmacological chaperone migalastat compared with enzyme replacement therapy in Fabry disease: 18-month results from the randomised phase III ATTRACT study
Derralynn A Hughes, Kathleen Nicholls, Suma P Shankar, et al.
Page
of 40